Literature DB >> 16690919

Activation of early gene transcription in polyomavirus BK by human immunodeficiency virus type 1 Tat.

Timothy Gorrill1, Mariha Feliciano, Ruma Mukerjee, Bassel E Sawaya, Kamel Khalili, Martyn K White.   

Abstract

Polyomavirus BK (BKV) is a serious problem for immunocompromised patients, where latent virus can enter into the lytic cycle causing cytolytic destruction of host cells. BKV infects >80% of the population worldwide during childhood and then remains in a latent state in the kidney. In the context of immunosuppression in kidney transplant patients, reactivation of the viral early promoter (BKV(E)) results in production of T antigen, enabling virus replication and transition from latency to the lytic phase, causing polyomavirus-associated nephropathy. Reactivation of BKV can also cause complications such as nephritis, atypical retinitis and haemorrhagic cystitis in AIDS patients. Here, the effects of human immunodeficiency virus type 1 (HIV-1) proteins Tat and Vpr on BKV transcription were investigated and it was demonstrated that Tat dramatically stimulated BKV(E). Site-directed mutagenesis analysis of potential Tat-responsive transcriptional motifs complemented by an electrophoretic mobility shift assay (EMSA) showed that Tat activated BKV(E) by inducing binding of the NF-kappaB p65 subunit to a kappaB motif near the 3' end of BKV(E). In addition, a sequence within the 5' UTR of BKV(E) transcripts (BKV(E)-TAR) was identified that is identical to the HIV-1 transactivation response (TAR) element. The BKV(E)-TAR sequence bound TAT in RNA EMSA assays and deletion of the BKV(E)-TAR sequence eliminated Tat transactivation of BKV(E) transcription. Thus, Tat positively affected BKV(E) transcription by a dual mechanism and this may be important in diseases involving BKV reactivation in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690919     DOI: 10.1099/vir.0.81569-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Molecular characterization of BK virus in patients infected with human immunodeficiency virus.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  Med Microbiol Immunol       Date:  2015-10-26       Impact factor: 3.402

Review 2.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

3.  Association of autism with polyomavirus infection in postmortem brains.

Authors:  Carla Lintas; Laura Altieri; Federica Lombardi; Roberto Sacco; Antonio M Persico
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

4.  A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient.

Authors:  Nicole M Broekema; Johanna R Abend; Shauna M Bennett; Janet S Butel; John A Vanchiere; Michael J Imperiale
Journal:  Virology       Date:  2010-09-24       Impact factor: 3.616

Review 5.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

6.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

Review 7.  Regulation of gene expression in primate polyomaviruses.

Authors:  Martyn K White; Mahmut Safak; Kamel Khalili
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 8.  Viruses and kidney disease: beyond HIV.

Authors:  Meryl Waldman; Vickie Marshall; Denise Whitby; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

9.  Modulation of JC virus transcription by C/EBPbeta.

Authors:  Luca Romagnoli; Hassen S Wollebo; Satish L Deshmane; Ruma Mukerjee; Luis Del Valle; Mahmut Safak; Kamel Khalili; Martyn K White
Journal:  Virus Res       Date:  2009-09-09       Impact factor: 3.303

10.  The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10.

Authors:  Jing Qu; Qi Zhang; Youxing Li; Weiyong Liu; Lvxiao Chen; Ying Zhu; Jianguo Wu
Journal:  BMC Immunol       Date:  2012-04-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.